Citation Impact 2023 Journal Impact Factor: 9.5 5-year Journal Impact Factor: 9.4 Source Normalized Impact per Paper (SNIP): 1.953 SCImago Journal Rank (SJR): 3.024 Speed 2024 Submission to first editorial decision (median days): 7 Submission to acceptance (median days): 71 ...
Biomarker Research encompasses every aspect of biomarker investigation from all biomedical disciplines. The journal recognizes that the study of biomarkers ...
Biomarker Research(2023-2024年最新版数据) 按JIF指标学科分区收录子集分区排名百分位 学科:MEDICINE, RESEARCH & EXPERIMENTALSCIEQ113 / 189 93.4% 学科:ONCOLOGYSCIEQ131 / 322 90.5% 按JCI指标学科分区收录子集分区排名百分位 学科:MEDICINE, RESEARCH & EXPERIMENTALSCIEQ120 / 189 ...
Evolution of the number of total citation per document and external citation per document (i.e. journal self-citations removed) received by a journal's published documents during the three previous years. External citations are calculated by subtracting the number of self-citations from the total...
To assess our hypotheses, we embraced the challenge of identifying reliable biomarkers for heart disease and stroke, which, despite being the leading cause of death worldwide and decades of research, lacks reliable biomarkers and risk stratification tools. We showed that raw R-R interval data and...
Abnormal alterations in human epidermal growth factor receptor 2 (HER2, neu, and erbB2) are associated with the development of many tumors. It is currently a crucial treatment for multiple cancers. Advanced in molecular biology and further exploration of
‘omics’ type of data could provide a holistic view and collective insights into the mechanisms underlying patient’s response or resistance to therapy and thus aids in the selection of clinically relevant biomarkers for further validation. In the liquid biopsy research field, machine learning is ...
The research report provides the latest information on the market drivers, challenges, and opportunities in the global biomarker technologies market. The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets...
Biomarker Research volume 11, Article number: 28 (2023) Cite this article 11k Accesses 3 Altmetric Metrics details Abstract Immune checkpoint inhibitors (ICIs) targeting PD-1 or PD-L1 have emerged as a revolutionary treatment strategy for human cancer patients. However, as the response rate to ...
Abnormal alterations in human epidermal growth factor receptor 2 (HER2, neu, and erbB2) are associated with the development of many tumors. It is currently a crucial treatment for multiple cancers. Advanced in molecular biology and further exploration of